Kumar Kamlesh Singh

This inventor holds 16 USPTO granted patents and 17 published patent applications and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Cadila Healthcare Limited, Zydus Lifesciences Limited. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kumar Kamlesh Singh. Retrieved from https://idiyas.com/inventor/kumar-kamlesh-singh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 17)

% Patents Active = 62.5

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 37(Granted Patents)

Location History:

Ahmedabad, IN (2016 - 2017)
Ahmedabad-Gujarat, IN (2018)
Gujarat, IN (2016 - 2024)

Company Filing History:

12 out of 131

Cadila Healthcare Limited

patents

4 out of 13

Zydus Lifesciences Limited

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Quinolone Compound

Triaminopyrimidine

Pyrrole Derivative

Isoxazoline

Grapiprant

Apalutamide

Vortioxetine

Rifaximin

Linagliptin

Androgen Receptor Antagonist

Apixaban

Dasatinib

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12774269 - Quinolone compound in solid forms and processes for the preparation thereof (2026-10-27),

2. 12378223 - Process for preparation of triaminopyrimidine compound and intermediates thereof (2025-08-05),

3. 12201611 - Composition comprising high purity pyrrole derivative and method for preparation thereof (2025-01-21),

4. 12065414 - Process for preparation of isoxazoline substituted benzamide compound (2024-08-20),

5. 11254675 - Process for preparation of grapiprant (2022-02-22),

6. 10934269 - Process for preparation of apalutamide (2021-03-02),

7. 10807965 - Process for preparation of apalutamide (2020-10-20),

8. 10414741 - Amorphous vortioxetine and salts thereof (2019-09-17),

9. 9988398 - Crystalline form of rifaximin and process for its preparation (2018-06-05),

10. 9879011 - Amorphous form of linagliptin and process for preparation thereof (2018-01-30),

11. 9611225 - Process for preparation of androgen receptor antagonist (2017-04-04),

12. 9603846 - Process for the preparation of apixaban (2017-03-28),

13. 9439903 - Process for the preparation of amorphous imatinib mesylate (2016-09-13),

14. 9409912 - Process for the preparation of sitagliptin phosphate (2016-08-09),

15. 9351957 - Amorphous form of apremilast (2016-05-31),

Title: **Kumar Kamlesh Singh: Innovator in Pharmaceutical Chemistry**

Introduction

Kumar Kamlesh Singh is a prominent inventor based in Gujarat, India, known for his significant contributions to pharmaceutical chemistry. With a portfolio of 14 patents, he has made substantial advancements, particularly in the development of innovative chemical compositions and processes.

Latest Patents

Among his latest patents, one noteworthy invention is a composition comprising a high purity pyrrole derivative, specifically focusing on Saroglitazar magnesium. This composition boasts a purity of 99.0% or more and includes various specific aldehyde compounds, diketo oxirane compounds, and other derivatives, each present in minimal amounts by weight. Furthermore, he has developed a process for preparing isoxazoline-substituted benzamide compounds, which also includes methods for synthesizing Fluralaner and its intermediates. These inventions highlight his dedication to enhancing the efficacy and purity of pharmaceutical products.

Career Highlights

Kumar Kamlesh Singh has worked with prestigious organizations such as Cadila Healthcare Limited and Zydus Lifesciences Limited. His experience in these companies has enriched his expertise in pharmaceutical innovations, enabling him to develop cutting-edge chemical solutions that meet industry standards.

Collaborations

Throughout his career, Kumar has collaborated with esteemed colleagues, including Nikhil Amar Singh and Shriprakash Dhar Dwivedi. These partnerships have not only fostered a creative environment but have also contributed to the successful development of his various patented inventions.

Conclusion

Kumar Kamlesh Singh continues to play a critical role in the field of pharmaceutical innovation. His extensive portfolio of patents and collaborative work not only reflects his expertise as an inventor but also underscores his commitment to advancing healthcare solutions through innovative chemistry.

Profile summary based on public USPTO records.